Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06299215
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-02-09
Brief Title:
Factors and Prognosis of Obstructive Pyelonephritis Patients
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Factors Associated With the Prognosis of Patients Admitted to for Acute Obstructive Pyelonephritis
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PYELO-OBS
Brief Summary:
Acute obstructive pyelonephritis is a condition with a high risk of complications and may require admission to the intensive care unit
Most of the available data on this condition comes from small retrospective single-centre series
To date no large-scale study has examined the factors associated with the prognosis of patients admitted to intensive care for acute obstructive pyelonephritis
The aim of this study is to describe the population and prognosis of patients admitted to the intensive care unit for the management of acute obstructive pyelonephritis and to identify factors associated with a poor prognosis in these patients
Most of the available data on this condition comes from small retrospective single-centre series
To date no large-scale study has examined the factors associated with the prognosis of patients admitted to intensive care for acute obstructive pyelonephritis
The aim of this study is to describe the population and prognosis of patients admitted to the intensive care unit for the management of acute obstructive pyelonephritis and to identify factors associated with a poor prognosis in these patients
Detailed Description:
The retrospective and multicenter study consists of a retrospective and pseudonymous collection of data from medical reports of patients treated over the period 2015-2022 in each intensive care unit agreeing to participate
Investigators from each participating center will be responsible for screening on all hospitalized patients over the period 2015-2022 Patients who have been hospitalized for the management of acute obstructive pyelonephritis will be included in the absence of non-inclusion criteria
Investigators from each participating center will be responsible for screening on all hospitalized patients over the period 2015-2022 Patients who have been hospitalized for the management of acute obstructive pyelonephritis will be included in the absence of non-inclusion criteria
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None